Published in Lancet on July 05, 1986
Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ (1988) 9.71
What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer (1987) 6.20
The growth law of primary breast cancer as inferred from mammography screening trials data. Br J Cancer (1998) 1.38
Prognosis in women with interval breast cancer: population based observational cohort study. BMJ (2012) 1.00
A study of interval breast cancer within the NHS breast screening programme. J Clin Pathol (2000) 0.99
Breast cancer survival and prognosis by screening history. Br J Cancer (2013) 0.89
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med (1998) 5.66
Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst (1993) 4.59
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
Evidence of prenatal influences on breast cancer risk. Lancet (1992) 4.25
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
Transient increase in the risk of breast cancer after giving birth. N Engl J Med (1994) 4.08
Sexually transmitted infection as a cause of anal cancer. N Engl J Med (1997) 4.05
Potential contribution of computer-aided detection to the sensitivity of screening mammography. Radiology (2000) 4.02
Infections as a major preventable cause of human cancer. J Intern Med (2000) 3.96
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. N Engl J Med (1996) 3.79
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
Stressful life events and Graves' disease. Lancet (1991) 3.63
Should the mission of epidemiology include the eradication of poverty? Lancet (1998) 3.42
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA (2001) 3.37
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ (1998) 3.34
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst (1994) 2.81
Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening? Lancet (2000) 2.75
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.69
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (2000) 2.65
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol (1999) 2.64
Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer (1990) 2.61
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet (1990) 2.58
International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control (1997) 2.52
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology (1991) 2.51
Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51
Increasing cancer risk in younger birth cohorts in Sweden. Lancet (1993) 2.39
Testicular cancer in nine northern European countries. Int J Cancer (1994) 2.32
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer (1989) 2.30
Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst (1996) 2.29
The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer (2003) 2.24
Exposure to dioxins as a risk factor for soft tissue sarcoma: a population-based case-control study. J Natl Cancer Inst (1990) 2.22
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16
Perinatal measles infection and subsequent Crohn's disease. Lancet (1994) 2.11
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06
Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol (1998) 2.06
[Meta-analysis is a good help for literature review. It makes the analysis of earlier studies more efficient and more objective]. Lakartidningen (1999) 2.02
Pesticides and cancer. Cancer Causes Control (1997) 2.00
Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98
Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Stat Med (1995) 1.93
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer. J Natl Cancer Inst (1993) 1.87
Observed and relative survival after aortic valve replacement. J Am Coll Cardiol (2000) 1.86
Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med (2000) 1.83
Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst (1989) 1.82
Surgical anatomy of human parathyroid glands. Surgery (1984) 1.81
Breast screening, prognostic factors and survival--results from the Swedish two county study. Br J Cancer (1991) 1.80
Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet (1986) 1.79
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79
Country profile: Sweden. Lancet (1996) 1.76
Risk factors for oesophageal cancer in northeast China. Int J Cancer (1994) 1.73
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. J Natl Cancer Inst (1996) 1.71
Effect of breast cancer screening after age 65. J Med Screen (1995) 1.69
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer (1997) 1.69
Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J (2000) 1.68
Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst (1997) 1.68
Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer (2000) 1.67
Sternal wound complications--incidence, microbiology and risk factors. Eur J Cardiothorac Surg (1997) 1.66
Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology (1992) 1.65
Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology (1994) 1.64
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res (1999) 1.63
Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst (1995) 1.62
Twin membership and breast cancer risk. Am J Epidemiol (1992) 1.62